Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fisher Wallace | UNKNOWN |
Not provided
Not provided
Not provided
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device (CES) for the treatment of insomnia characterized by difficulties with sleep maintenance using a 20-minute treatment right before bedtime.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experiment Arm | Experimental | Active Fisher Wallace device for full 8 weeks |
|
| Sham Arm | Sham Comparator | Sham Fisher Wallace device for 4 weeks, then cross over at 4 weeks to active device. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fisher Wallace Neurostimulation Device | Device | a Cranial Electrotherapy Stimulator Device (CES). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in total sleep per night at week 4 between active and sham arm | Measured by Fitbit Charge 4 connected health device work on the wrist | baseline versus week 4 |
| Measure | Description | Time Frame |
|---|---|---|
| Device Tolerance and Safety measured by SAFTEE | assessment of safety and adverse events | 4 weeks from baseline |
| Change in WASO (wake after sleep onset) between sham versus active arms | measured by Fitbit Charge 4 connected health device worn on the wrist |
Not provided
Age greater than or equal to 21 US resident Can receive packages to their home via UPS/Fedex/USPS Read/write English Insomnia Severity Index Score Greater than 14 Diagnosis of insomnia by a medical physician Subjects with a Generalized Anxiety Diagnosis will be excluded Have not contemplated suicide in the past year Not been institutionalized for mental health issues. Not currently being treated for or suspect a mental health issue Not currently experiencing problems with alcohol or drug abuse Can commit to not drinking alcohol 4 hours before bedtime for the duration of the study Not taking medications affecting the nervous system (e.g. psychiatric medications) Not taking hypnotics or any sleep aid or marijuana (in any form) Can commit to one (1) 20 minute session per day for 8 weeks Has not used a brain stimulation treatment in one year No suspected or known history of heart disease No pacemaker, or any form of medical electronics, including but not limited to a deep brain stimulator, electronic stent, etc.
Not under medical supervision for other serious medical condition Not taking opioids No pain or headaches that interrupt sleep Not participating in any other sleep study Not experiencing restless leg syndrome No Nickel Allergy No Sleep Apena as measured by STOP-Bang Assessment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| ProofPilot (Remote Virtual Trial) | New York | New York | 10003 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jul 29, 2022 | Aug 23, 2022 | 2 |
| ID | Term |
|---|---|
| D007319 | Sleep Initiation and Maintenance Disorders |
| ID | Term |
|---|---|
| D020919 | Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Sham Device
| baseline versus week 4 |
| Change in Insomnia Severity between Sham versus active arms | measured by the self report Insomnia Severity Index (ISI) | baseline versus week 4 |
| D001523 |
| Mental Disorders |